While this review focuses on ATF5, CEBPB and CEBPD in the context of brain cancers, it is important to consider, as we briefly do here, the roles of these transcription factors in other types of cancers and how the targeted peptide drugs discussed here may be used to treat these as well. This evidence concerns the gene CEBPD and cancer.